Artificial Pancreas (AP) Technology Take the Stage at the 75th Annual American Diabetes Association (ADA) Conference

Artificial Pancreas (AP) Technology Take the Stage at the 75th Annual American Diabetes Association (ADA) Conference

Commercialization of hybrid closed-loop systems, dual-hormone AP therapy and pediatric studies were hot topics Watch video of UVA researcher Stacey Anderson, M.D., talking about the DiAs AP system. The 2015 ADA conference in Boston, MA highlighted the impressive progress that has been made in developing AP technology in less than a decade, and provided a […]

Leading the Charge: Virginia’s Artificial Pancreas System

The University of Virginia’s Diabetes Assistant system is on the road to automate insulin delivery Researchers at the University of Virginia (UVA) have been working for nearly a decade to turn a novel concept called the artificial pancreas (AP) system into working medical technology by adding automation to the pump that will help reduce the […]

Study Aims to Prevent Kidney Damage for T1D

A promising JDRF-funded trial looks at allopurinol—a 50-year-old gout treatment drug—to slow or stop loss of kidney function in people living with Type 1 Diabetes (T1D) The Preventing Early Renal Function Loss in Diabetes (PERL) Consortium is conducting a multi-site, international clinical trial of allopurinol as an intervention for T1D-related kidney disease. Allopurinol is an […]

JDRF Top Research Advances

The past year brought about significant advances in type 1 diabetes (T1D) therapies that are improving how people live with the disease and bringing us closer to a biological cure and universal advances that have helped make this a pivotal moment in the history of T1D research. ENCAPSULATION The JDRF Encapsulation Program funds development of […]

Well-Timed AP Technology Offers Peace of Mind in the UK

A JDRF-funded study at the University of Cambridge showed that an overnight treat-to-range device improved glucose control A recent JDRF-funded study at the University of Cambridge has found that unsupervised, at-home use of a treat-to-range artificial pancreas system can improve blood-glucose control throughout the night and into the next day. You can click on the […]

Two-year $300 Million Special Diabetes Program Extended

In an overwhelming vote, the U.S. Senate approved a two-year extension of the Special Diabetes Program (SDP)—an initiative that accounts for roughly one-third of all federally-funded type 1 diabetes (T1D) research in the United States. “JDRF staff and our network of advocacy leaders and passionate volunteers all across the U.S. work tirelessly every day to […]

JDRF Draws a Winning Encapsulation Strategy

JDRF video demonstrates the differences between micro-encapsulation and macro-encapsulation A new video, “Sketching Encapsulation,” was created for JDRF’s FY2014 Annual Report. Albert J. Hwa, Ph.D., Director of Discovery Research at JDRF, explains encapsulation and outlines four encapsulation projects that are currently supported by JDRF. “Over the last seven years, JDRF has cultivated several encapsulation research […]

Your design can supercharge T1D research

Kids, start your sketching! Children living with type 1 diabetes (T1D), ages 5 to 18, are encouraged to let their imaginations race for the checkered flag in the 2015 Race Car Design Contest for JDRF, hosted by Motorcraft/Quick Lane Tire and Auto Centers. From now until March 12, children can submit their JDRF-inspired race car […]